Extraordinary/ Special General Meeting::Voluntary

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Security
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14

Announcement Details

Announcement Title
Extraordinary/ Special General Meeting
Date &Time of Broadcast
30-Sep-2020 17:44:06
Status
New
Announcement Reference
SG200930XMETNCMU
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board

Event Narrative

Narrative Type
Narrative Text
Additional Text1: To consider and approve the proposed re-appointment of Mr. Li Liqun as Executive and Non-Independent Director of the Company; and
2: To consider and approve the proposed amendments to the Articles of Association of the Company and the application for changes in the industrial and commercial registration.

Event Dates

Meeting Date and Time
30/09/2020 14:00:00
Response Deadline Date
28/09/2020 14:00:00

Event Venue(s)

Place
Venue(s)
Venue details
Meeting VenueAn extraordinary general meeting of the Company will be held at the meeting room of Zhongxin Mansion, No. 17 Baidi Road, Nankai District, Tianjin, the People s Republic of China 300193 on 30 September 2020 at 2:00 p.m.. Concurrently, the Extraordinary General Meeting will be held by electronic means for holders of S shares in Singapore.

Attachments